Krystal Biotech Inc
F:4KB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Krystal Biotech Inc
F:4KB
|
US |
|
A
|
Air China Ltd
F:AD2
|
CN |
|
CHAPTERS Group AG
F:CHG
|
DE |
|
Sunshine Insurance Group Co Ltd
F:E57
|
CN |
|
D
|
Dios Fastigheter AB
F:D1F
|
SE |
|
V
|
Verisign Inc
F:VRS
|
US |
|
B
|
BlackRock Inc
SWB:BLQA
|
US |
|
Verisk Analytics Inc
F:VA7A
|
US |
|
M
|
Moshi Moshi Retail Corporation PCL
SET:MOSHI
|
TH |
|
LVMH Moet Hennessy Louis Vuitton SE
PAR:MC
|
FR |
|
M
|
Medifast Inc
XBER:MDF
|
US |
|
Medinova Diagnostic Services Ltd
BSE:526301
|
IN |
|
N
|
Northern Star Resources Ltd
OTC:NESRF
|
AU |
|
Sichuan Changhong Electric Co Ltd
SSE:600839
|
CN |
|
CEZ as
F:CEZ
|
CZ |
|
NVR Inc
NYSE:NVR
|
US |
|
T
|
Trinity Ltd
F:7TR
|
HK |
|
B
|
Baidu Inc
F:B1C
|
CN |
|
T
|
Tenable Holdings Inc
F:TE7
|
US |
|
M
|
Marin Software Inc
F:2MAA
|
US |
|
E
|
electroCore, Inc.
F:43E
|
US |
|
Online Blockchain PLC
F:RCQ
|
UK |
|
I
|
Interpublic Group of Companies Inc
DUS:IPG
|
US |
|
Lloyds Metals And Energy Ltd
BSE:512455
|
IN |
Wall St Price Targets
4KB Price Targets Summary
Krystal Biotech Inc
According to Wall Street analysts, the average 1-year price target for 4KB is 145.65 EUR with a low forecast of 91.82 EUR and a high forecast of 178.93 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4KB's stock price target?
Price Target
145.65
EUR
According to Wall Street analysts, the average 1-year price target for 4KB is 145.65 EUR with a low forecast of 91.82 EUR and a high forecast of 178.93 EUR.
What is the Revenue forecast for Krystal Biotech Inc?
Projected CAGR
32%
The compound annual growth rate for Revenue over the next 3 years is 32%.
What is the Gross Profit forecast for Krystal Biotech Inc?
Projected CAGR
38%
The compound annual growth rate for Gross Profit over the next 3 years is 38%.
What is the Operating Income forecast for Krystal Biotech Inc?
Projected CAGR
56%
The compound annual growth rate for Operating Income over the next 3 years is 56%.
What is the Pre-Tax Income forecast for Krystal Biotech Inc?
Projected CAGR
44%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 44%.
What is the Net Income forecast for Krystal Biotech Inc?
Projected CAGR
35%
The compound annual growth rate for Net Income over the next 3 years is 35%.
